SESN1 and heart disorder: We further demonstrate that miR-16-5p promotes apoptosis in cardiomyocytes via SESN1, hence, the miR-16-5p-SESN1 axis should be considered as a potential target for new treatment strategies for heart disease patients that are unable to undergo exercise intervention-based early adaptation due to aging or severe HF.